Skip to main content Skip to section navigation Skip to footer
French

Acasti Pharma Inc.

  • English
  • About Us
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Pipeline
    • GTX-104
    • GTX-102
    • GTX-101
  • Investor Relations
    • Overview
    • News / Events
    • Company Info
    • Financial Results
    • Stock Data
    • Regulatory Filings
    • Governance
  • Newsroom
  • Careers
  • Contact
  • French

Press Releases

Investor Relations

Investor Relations

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Media
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • NASDAQ: ACST
    • Analyst Coverage
  • Regulatory Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
    • SEDAR
    • Tax Notifications
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News / Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts

Acasti Signs Manufacturing Agreement

Jul 31, 2013

Acasti Announces First Quarter Results

Jul 15, 2013

Acasti Reports Results of Annual and Special Meeting

Jun 28, 2013

Acasti Announces Fiscal 2013 Results and Provides Update on Status of Clinical Trials

May 22, 2013

Acasti Pharma Presents Preliminary Data Moving Forward With Clinical Strategy

Mar 19, 2013

Acasti Pharma Reports Its Third Quarter Results

Jan 15, 2013

Acasti Pharma Shares to Trade on NASDAQ

Jan 7, 2013

Acasti Pharma Provides an Insight of Its Current Clinical Trials Results

Dec 17, 2012

Acasti Pharma Becomes Royalty Free

Dec 4, 2012

Acasti Pharma Provides Update After Explosion at Neptune's Plant

Nov 12, 2012
rss_feed News RSS
  • Prev
    • 1...
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2023 Acasti Pharma Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap